Eam Investors, LLC Capricor Therapeutics, Inc. Transaction History
Eam Investors, LLC
- $616 Million
- Q4 2024
A detailed history of Eam Investors, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 38,276 shares of CAPR stock, worth $492,229. This represents 0.09% of its overall portfolio holdings.
Number of Shares
38,276
Previous 69,925
45.26%
Holding current value
$492,229
Previous $1.06 Million
50.14%
% of portfolio
0.09%
Previous 0.18%
Shares
2 transactions
Others Institutions Holding CAPR
# of Institutions
133Shares Held
16MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$29.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$28.9 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$28.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$20.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$11.3 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $313M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...